awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33367787-667D8ABC-A9F0-40B8-8AFC-159057733442
Q33367787-667D8ABC-A9F0-40B8-8AFC-159057733442
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33367787-667D8ABC-A9F0-40B8-8AFC-159057733442
A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.
P2860
Q33367787-667D8ABC-A9F0-40B8-8AFC-159057733442
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33367787-667D8ABC-A9F0-40B8-8AFC-159057733442
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
68d7f3b6b3b1cf5232da07d00ac17385358d5b93
P2860
Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?